Clinical Trials List
2020-08-31 - 2027-12-31
Phase III
Recruiting11
ICD-10C15.9
Malignant neoplasm of esophagus, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.9
Malignant neoplasm of esophagus, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Huang Chen 無
- Chueh-Chuan Yen Division of Hematology & Oncology
- Rheun-Chuan Lee Division of Hematology & Oncology
- 謝春梅 無
- Yee Chao Division of Hematology & Oncology
- Chung-Pin Li 無
- 黃品逸 無
- Jiun-I Lai Division of Hematology & Oncology
- Yun-Cheng Hsieh 無
- 陳盛裕 未分科
- 蕭志柔 無
- 姜乃榕 無
- Yi-Ping Hung 無
- Shao-Jung Hsu 無
- 賴姿妤 無
- Sheng-Yu Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-Ching Wang 無
- Yu-Cheng Kuo 無
- Chi-Ching Chen 無
- Chun-Ru Chien 無
- Ming-Yu Lien 無
- 賴宥良 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mengting Peng 無
- Chi-Ting Liau 無
- 張鈞弼 無
- 詹頂立 無
- 曾振淦 無
- Po-Jung Su 無
- Cheng-Lung Hsu 無
- Chan-Keng Yang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
600 participants
